CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $815,000 | -88.9% | 250,793 | -82.5% | 0.02% | -90.9% |
| Q1 2020 | $7,332,000 | +29.7% | 1,432,032 | +15.5% | 0.28% | +58.0% |
| Q4 2019 | $5,654,000 | -25.5% | 1,239,983 | 0.0% | 0.17% | -38.1% |
| Q3 2019 | $7,589,000 | +0.5% | 1,239,983 | 0.0% | 0.28% | +20.6% |
| Q2 2019 | $7,551,000 | +18.3% | 1,239,983 | +7.8% | 0.23% | +17.1% |
| Q1 2019 | $6,383,000 | +37.5% | 1,150,000 | +40.2% | 0.20% | +39.2% |
| Q4 2018 | $4,641,000 | – | 820,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |